Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Hemostatic Agents and Tourniquet in Abdominal Myomectomy
NCT05806307Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Mar 2023
- Primary completion
- Oct 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of misoprostol, oxytocin, carbetocin, vasopressin, tranexamic acid in uterine leiomyoma, sponsored by Cairo University. Status: unknown.
02
Drugs
misoprostoloxytocincarbetocinvasopressintranexamic acid
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT05806307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806307.